openPR Logo
Press release

Gamma Secretase Market -Pipeline Review, H2 2017

"The Latest Research Report Gamma Secretase (EC 3.4.23.)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

About Gamma Secretase Market

Gamma Secretase (EC 3.4.23.) pipeline Target constitutes close to 19 molecules. Out of which approximately 16 molecules are developed by companies and remaining by the universities/institutes. The latest report Gamma Secretase (EC 3.4.23.)-Pipeline Review, H2 2017, outlays comprehensive information on the Gamma Secretase (EC 3.4.23.) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Request For Sample Report @ https://www.marketresearchreports.biz/sample/sample/1339573

Gamma Secretase (EC 3.4.23.)-Gamma secretase is a multi-subunit protease complex, itself an integral membrane protein, that cleaves single-pass transmembrane proteins at residues within the transmembrane domain. The most well-known substrate of gamma secretase is amyloid precursor protein, when cleaved by both gamma and beta secretase, produces a short 39-42 amino acid peptide called amyloid beta whose abnormally folded fibrillar form is the primary component of amyloid plaques found in the brains of Alzheimer's disease patients. Gamma secretase is also critical in the related processing of the Notch protein. The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 3, 11 and 1 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 1 and 2 molecules, respectively. Report covers products from therapy areas Central Nervous System, Oncology and Ear Nose Throat Disorders which include indications Alzheimer's Disease, Hearing Disorders, Acute Lymphoblastic Lymphoma, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Brain Cancer, Burkitt Lymphoma, Glioblastoma Multiforme (GBM), Leukemias, Medulloblastoma, Metastatic Breast Cancer, Soft Tissue Sarcoma, Solid Tumor and T-Cell Leukemia.

Furthermore, this report also reviews key players involved in Gamma Secretase (EC 3.4.23.) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

View Sample PDF @ https://www.marketresearchreports.biz/reports/1339573/gamma-secretase-ec-3423-pipeline-review-h2-2017-market-research-reports.pdf

Scope

- The report provides a snapshot of the global therapeutic landscape for Gamma Secretase (EC 3.4.23.)
- The report reviews Gamma Secretase (EC 3.4.23.) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Gamma Secretase (EC 3.4.23.) targeted therapeutics and enlists all their major and minor projects
- The report assesses Gamma Secretase (EC 3.4.23.) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Gamma Secretase (EC 3.4.23.) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Gamma Secretase (EC 3.4.23.)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Gamma Secretase (EC 3.4.23.) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Have Any Query? Ask Our Expert @ https://www.marketresearchreports.biz/sample/enquiry/1339573

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Gamma Secretase (EC 3.4.23.)-Overview 7
Gamma Secretase (EC 3.4.23.)-Therapeutics Development 8
Products under Development by Stage of Development 8
Products under Development by Therapy Area 9
Products under Development by Indication 10
Products under Development by Companies 11
Products under Development by Universities/Institutes 14
Gamma Secretase (EC 3.4.23.)-Therapeutics Assessment 16
Assessment by Mechanism of Action 16
Assessment by Route of Administration 18
Assessment by Molecule Type 20
Gamma Secretase (EC 3.4.23.)-Companies Involved in Therapeutics Development 22
Astellas Pharma Inc 22
Bristol-Myers Squibb Co 22
Critical Outcome Technologies Inc 22
Lipopharma Therapeutics SL 23
Merck & Co Inc 23
NeuroGenetic Pharmaceuticals Inc 24
Pfizer Inc 24
Stemline Therapeutics Inc 25
Takeda Pharmaceutical Co Ltd 25
Gamma Secretase (EC 3.4.23.)-Drug Profiles 27
AS-2715348-Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
BMS-932481-Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
BMS-986133-Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
GSI-34-Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
LP-226A1-Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
LY-3056480-Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
NGP-328-Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
NGP-555-Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
nirogacestat-Drug Profile 36
Product Description 36
Mechanism Of Action 36
R&D Progress 36
Peptides to Inhibit PSEN1 for Alzheimers Disease-Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
PF-06648671-Drug Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
SL-301-Drug Profile 41
Product Description 41
Mechanism Of Action 41
R&D Progress 41
SL-302-Drug Profile 42
Product Description 42
Mechanism Of Action 42

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gamma Secretase Market -Pipeline Review, H2 2017 here

News-ID: 761875 • Views: 99

More Releases from MarketResearchReports.biz

Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is

All 5 Releases


More Releases for Gamma

Global Gamma Globulin Market Research Report
This report studies the global Gamma Globulin market status and forecast, categorizes the global Gamma Globulin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Grifols Baxter Octapharma Biotest Kedrion Geographically, this report studies the top producers and consumers, focuses on product
Gamma Knife Market - Global Industry Analysis 2024.
Gamma knife is an advanced radiation therapy for the treatment of cancer in adults and children. Gamma knife is not really a knife; it is a beam of highly focused gamma rays, to precisely cut or destroy the tumor or damaged cells, generally in the brain, causing little or no damage to the surrounding normal cells. Gamma knife technology is used to treat medium brain tumors, trigeminal neuralgia, epilepsy, nerve
Gamma-Butyrolactone Market 2017 - BASF, Ashland, LyondellBasell
Apex Research, recently published a detailed market research study focused on the "Gamma-Butyrolactone Market" across the global, regional and country level. The report provides 360° analysis of "Gamma-Butyrolactone Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Gamma-Butyrolactone industry, and estimates the future trend of Gamma-Butyrolactone market on the basis of this
Global Gamma Probe Sales Market Report 2017
Report Hive Market Research Released a New Research Report of 108 pages on Title " Global Gamma Probe Sales Market Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Gamma Probe market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global
Global Gamma Globulin Market Research Report 2017
Report Hive Market Research Released a New Research Report of 109 pages on Title " Global Gamma Globulin Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. Gamma globulins are a class of globulins, recognized by their position after serum protein electrophoresis. The most noteworthy gamma globulins are immunoglobulins (antibodies), albeit a few immunoglobulins are not gamma globulins, and some gamma globulins are not immunoglobulins. In this report, the global Gamma
Gamma Knife Market: Technologies, Markets and Players
Gamma knife is an advanced radiation therapy for the treatment of cancer in adults and children. Gamma knife is not really a knife; it is a beam of highly focused gamma rays, to precisely cut or destroy the tumor or damaged cells, generally in the brain, causing little or no damage to the surrounding normal cells. Gamma knife technology is used to treat medium brain tumors, trigeminal neuralgia, epilepsy, nerve